Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Fresenius SE & Co. KGaA buy gerihouse

Start price
€28.31
07.01.13 / 50%
Target price
€33.00
31.01.13
Performance (%)
7.02%
End price
€30.30
31.01.13
Summary
This prediction ended on 31.01.13 with a price of €30.30. The BUY prediction by gerihouse finished with a performance of 7.02%. gerihouse has 50% into this prediction

Fresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.

Performance without dividends (%)
Name 1w 1m 1y 3y
Fresenius SE & Co. KGaA -0.460% -0.460% 1.664% -32.306%
iShares Core DAX® 4.015% 2.971% 16.492% 19.144%
iShares Nasdaq 100 2.755% 0.503% 40.029% 50.636%
iShares Nikkei 225® -0.826% -5.057% 14.566% 2.379%
iShares S&P 500 2.330% 0.720% 30.194% 44.181%

Comments by gerihouse for this prediction

In the thread Fresenius SE & Co. KGaA diskutieren
Prediction Buy
Perf. (%) 7.02%
Target price 33.000
Change
Ends at 31.01.13

Positive Geschäftsdynamik

Merrill Lynch hat das Kursziel für Fresenius von 101,00 auf 99,00 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Trotz der Herausforderungen für die Dialysetochter FMC dürfte der Medizinkonzern seinen Gewinn je Aktie im Zeitraum 2012 bis 2015 um durchschnittlich 14 Prozent pro Jahr steigern können, schrieb Analyst Ed Ridley-Day in einer Studie vom Freitag. Bei den Töchtern Kabi und Helios sei die positive Geschäftsdynamik hingegen ungebrochen

Prediction Buy
Perf. (%) 7.02%
Target price 33.000
Change
Ends at 31.01.13

(Vom Mitglied beendet)

Stopped prediction by gerihouse for Fresenius SE & Co. KGaA

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€43.94
08.07.21
€55.00
08.07.22
-34.74%
08.07.22

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€44.07
30.09.19
€50.00
12.10.19
-4.54%
12.10.19

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€46.00
12.07.19
€65.00
30.09.19
-4.21%
30.09.19

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€48.50
20.02.19
€70.00
24.05.19
-0.02%
24.05.19

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€40.26
04.11.14
€50.10
11.12.14
7.29%
11.12.14

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€22.90
02.11.11
€26.67
20.01.12
8.14%
20.01.12